Anastrozole trials for Hormone-receptor-positive Breast Cancer

All Anastrozole trials · All Hormone-receptor-positive Breast Cancer trials

Phase breakdown

Recruiting trials studying Anastrozole for Hormone-receptor-positive Breast Cancer

• Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
  NCT05524584 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ETHAN - ET for Male BC
  NCT05501704 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 9 locations
• Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
  NCT05467891 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 21 locations

Common questions

How many trials study Anastrozole for Hormone-receptor-positive Breast Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.